Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
M137089-250mg | 250mg | In stock | $9.90 | |
M137089-1g | 1g | In stock | $24.90 | |
M137089-5g | 5g | In stock | $80.90 | |
M137089-25g | 25g | In stock | $363.90 | |
M137089-100g | 100g | In stock | $1,308.90 |
Synonyms | insulin, semi-Lente | 4-Morpholineacetic acid, hydrochloride | R935788 | 2-morpholin-4-ylacetic acid hydrochloride | BCP10116 | CS-W001669 | 4-Morpholinylacetic acid HCl salt | J-515838 | F2130-0038 | 2-morpholinoacetic acid hydrochloride salt | SY032269 |
---|---|
Specifications & Purity | ≥95% |
Shipped In | Normal |
Product Description | Product Application: 4-Morpholineacetic acid hydrochloride is used as a pharmaceutical intermediate. |
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Pubchem Sid | 488199546 |
---|---|
Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488199546 |
IUPAC Name | 2-morpholin-4-ylacetic acid;hydrochloride |
INCHI | InChI=1S/C6H11NO3.ClH/c8-6(9)5-7-1-3-10-4-2-7;/h1-5H2,(H,8,9);1H |
InChi Key | ICGYBJNONRDZOP-UHFFFAOYSA-N |
Canonical SMILES | C1COCCN1CC(=O)O.Cl |
Isomeric SMILES | C1COCCN1CC(=O)O.Cl |
PubChem CID | 17750946 |
Molecular Weight | 181.62 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
G1811089 | Certificate of Analysis | Dec 19, 2023 | M137089 |
K2124601 | Certificate of Analysis | Sep 11, 2023 | M137089 |
K2124602 | Certificate of Analysis | Sep 11, 2023 | M137089 |
K2124605 | Certificate of Analysis | Sep 11, 2023 | M137089 |
D23191012 | Certificate of Analysis | Sep 29, 2021 | M137089 |
Solubility | Insoluble in water. |
---|---|
Melt Point(°C) | 179 °C |
Pictogram(s) | GHS05, GHS07 |
---|---|
Signal | Danger |
Hazard Statements | H315:Causes skin irritation H319:Causes serious eye irritation H335:May cause respiratory irritation H318:Causes serious eye damage |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P271:Use only outdoors or in a well-ventilated area. P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing. P403+P233:Store in a well-ventilated place. Keep container tightly closed. P362+P364:Take off contaminated clothing and wash it before reuse. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P305+P354+P338:IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses if present and easy to do. Continue rinsing. P317:Get emergency medical help. P337+P317:If eye irritation persists: Get medical help. P332+P317:If skin irritation occurs: Get medical help. P319:Get medical help if you feel unwell. |
1. Yang Zhou, Fan Tong, Weilong Gu, Siqin He, Xiaotong Yang, Jiamei Li, Yue-Dong Gao, Huile Gao. (2022) Co-delivery of photosensitizer and diclofenac through sequentially responsive bilirubin nanocarriers for combating hypoxic tumors. Acta Pharmaceutica Sinica B, 12 (1416). [PMID:35530138] |
1. Yang Zhou, Fan Tong, Weilong Gu, Siqin He, Xiaotong Yang, Jiamei Li, Yue-Dong Gao, Huile Gao. (2022) Co-delivery of photosensitizer and diclofenac through sequentially responsive bilirubin nanocarriers for combating hypoxic tumors. Acta Pharmaceutica Sinica B, 12 (1416). [PMID:35530138] |